Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Formycon AG

Market Cap 349M 400M 323M 302M 567M 37.75B 571M 3.83B 1.49B 18.58B 1.5B 1.47B 64.53B P/E 2026 *
-49.6x
P/E 2027 * 8.17x
Enterprise Value 418M 479M 387M 362M 680M 45.23B 684M 4.59B 1.78B 22.26B 1.8B 1.76B 77.3B EV / Sales 2026 *
5.75x
EV / Sales 2027 * 3.82x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day+0.25%
1 week-1.60%
Current month-12.92%
1 month-1.85%
3 months+13.89%
6 months-19.34%
Current year-23.12%
1 week 19.34
Extreme 19.34
21.35
1 month 19.34
Extreme 19.34
22.7
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
31.3
3 years 15.8
Extreme 15.8
69.6
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap.
25-02-20Buy

Chief Technology Officer

160 0.0009%
24-04-28Buy

Executive/Senior Manager

1,200 0.0068%
24-04-23Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-1.60%-24.16%-69.01% 400M
-0.08%+0.69%-11.16%-5.43% 43.13B
+1.52%+3.78%+314.86%+565.24% 34.65B
-0.22%+1.16%+5.36%+45.94% 30.03B
-2.19%-7.96%+5.81%-23.14% 28B
-1.90%-1.56%+10.24%+22.81% 24.45B
+0.28%+3.95% - - 14.34B
-2.81%-2.83%+47.18%+102.25% 13.14B
+0.38%-1.17%+5.24%+7.44% 12.53B
+0.19%+0.93%+98.17%+81.19% 12.25B
Average -0.46%+0.27%+50.17%+80.81% 21.29B
Weighted average by Cap. -0.41%+1.26%+64.87%+116.05%

Financials

2026 *2027 *
Net sales 72.73M 83.42M 67.36M 63.06M 118M 7.87B 119M 799M 310M 3.87B 313M 306M 13.45B 121M 139M 112M 105M 197M 13.13B 199M 1.33B 517M 6.46B 522M 511M 22.45B
Net income -7.19M -8.25M -6.66M -6.23M -11.69M -778M -11.76M -78.99M -30.61M -383M -30.95M -30.29M -1.33B 42.39M 48.61M 39.26M 36.75M 68.92M 4.59B 69.34M 466M 180M 2.26B 182M 179M 7.84B
Net Debt 69.04M 79.18M 63.94M 59.86M 112M 7.47B 113M 759M 294M 3.68B 297M 291M 12.77B 115M 132M 106M 99.62M 187M 12.43B 188M 1.26B 489M 6.12B 495M 484M 21.25B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
203
Date Price Change Volume
26-06-22 19.68 -0.30% 3,232
26-06-19 19.74 +0.71% 2,858
26-06-18 19.60 -1.71% 8,050
26-06-17 19.94 -0.20% 5,121
26-06-16 19.98 -0.10% 18,879
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.74EUR
Average target price
39.67EUR
Spread / Average Target
+100.95%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!